Pharmacotherapy (Record no. 1536)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 08444nam a2200409 a 4500 |
| 001 - CONTROL NUMBER | |
| control field | scn00350082 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210413150553.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m||||||||||||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr||n||||||||n |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 161126s2017||||nyu|||||s|||||||||||eng|| |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2016035246 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781259587481 (printISBN) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1259587487 (print-ISBN) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)955093124 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM263 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | WB 330 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.5/8 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | DiPiro, Joseph T., |
| Relator term | ath. |
| 245 10 - TITLE STATEMENT | |
| Title | Pharmacotherapy |
| Medium | [electronic resource] : |
| Remainder of title | A Pathophysiologic Approach, 10e / |
| Statement of responsibility, etc. | Joseph T DiPiro. |
| 246 30 - VARYING FORM OF TITLE | |
| Title proper/short title | Pharmacotherapy, A Pathophysiologic Approach, Tenth edition |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 10th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | New York, N.Y. : |
| Name of publisher, distributor, etc. | McGraw-Hill Education LLC., |
| Date of publication, distribution, etc. | c2017. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource : |
| Other physical details | ill., figs., tables. |
| 490 1# - SERIES STATEMENT | |
| Series statement | McGraw-Hill's AccessPharmacy |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and indexes. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Also issued in online and PDF version. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on cover image and table of contents, viewed on Nov. 26, 2016. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Physiology, Pathological. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Therapy. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Therapy. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Online version: |
| Title | Pharmacotherapy, A Pathophysiologic Approach. |
| Edition | Tenth edition. |
| Place, publisher, and date of publication | New York, N.Y. : McGraw-Hill Education LLC., |
| Qualifying information | 2017. |
| Record control number | (OCoLC)955093124 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | McGraw-Hill's AccessPharmacy. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://accesspharmacy.mhmedical.com/book.aspx?bookID=1861">http://accesspharmacy.mhmedical.com/book.aspx?bookID=1861</a> |
No items available.